(Q44225492)

1 December 2017

title

Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women (English)

1 reference

1 December 2017

1 reference

2

1 reference

1 December 2017

4

1 reference

1 December 2017

6

1 reference

1 December 2017

van Amelsvoort T

1

1 reference

1 December 2017

Robertson D

series ordinal

3

1 reference

1 December 2017

Whitehead M

series ordinal

5

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

published in

Psychoneuroendocrinology

1 reference

1 December 2017

volume

28

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

101-112

1 reference

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen replacement therapy and cognitive function in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Neuroendocrine control of growth hormone secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Pyridostigmine induced growth hormone release in mania: focus on the cholinergic/somatostatin system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

1 reference

7 January 2021

Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Is the risk of developing Alzheimer's disease greater for women than for men?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Senile dementia-Alzheimer's type and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Cognitive function in nondemented older women who took estrogen after menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effects of an estrogen antagonist on enzyme activities and [3H]estradiol nuclear binding in uterus, pituitary and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Ovarian steroids and the brain: implications for cognition and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Pyridostigmine-induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Growth hormone responses to pyridostigmine in schizophrenia: Evidence for cholinergic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estradiol 17 beta increases the number of muscarinic receptors in hypothalamic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900012-4

7 January 2021

10.1016/S0306-4530(02)00012-4

Identifiers

DOI

1 reference

1 December 2017

1 reference